Production of many products has been shifted to other factories, but J&J has repeatedly pushed back its target for getting all the recalled products back on store shelves and now doesn't expect that to happen until sometime next year.
No injuries have been linked to the recalls.
The company also is negotiating a settlement with the federal government, expected to be in the $2 billion range, over promoting prescription drugs for unapproved uses.
___Linda A. Johnson can be followed at â¿¿http://twitter.com/LindaJ_onPharma
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts